<DOC>
	<DOCNO>NCT01429792</DOCNO>
	<brief_summary>This multi-center study evaluate viral response patient chronic hepatitis C , genotype 1 , 2 , 3 &amp; 4 standard anti-viral treatment Pegasys ( peginterferon alfa-2a ) Copegus ( ribavirin ) . Patients receive weekly subcutaneous Pegasys plus daily oral Copegus 24 week ( genotype 2 &amp; 3 ) 48 week ( genotype 1 &amp; 4 ) . Patients identify slow responders/non-rapid virological responder eligible additional 24 week treatment .</brief_summary>
	<brief_title>A Study Evaluating Slow Response/Non-Rapid Response Patients With Chronic Hepatitis C , Genotype 1 , 2 , 3 &amp; 4 Treated With Pegasys ( Peginterferon Alfa-2a ) Copegus ( Ribavirin )</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Peginterferon alfa-2a</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>Adult patient , &gt; /= 18 year age Serologic evidence chronic hepatitis C , genotype 1 , 2 , 3 4 antiHCV antibody test Documented pretreatment HCV RNA quantitative result Compensated liver disease ( ChildPugh Grade A ) Patient receive standard combination treatment Pegasys ( peginterferon alfa2a Copegus ( ribavirin ) Decompensated liver disease ( ChildPugh Class B C cirrhosis ) Coinfection active hepatitis A and/or hepatitis B History evidence medical condition associate liver disease HCV Signs symptom hepatocellular carcinoma History poorly control thyroid disease , elevate TSH clinical manifestation thyroid disease Therapy antineoplastic treatment &lt; /= 6 month prior study day Diabetes mellitus subject receive insulin therapy Evidence severe retinopathy Pregnant breastfeed woman , male partner woman pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>